1991
An inhibition enzyme immunoassay, using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, for the serology of HIV-1 infections.
Publication
Publication
AIDS , Volume 5 - Issue 7 p. 893- 896
An inhibition enzyme immunoassay (IEIA), using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, was evaluated for its applicability to the serology of HIV-1 infections. Using panels of serum samples from seronegative and confirmed HIV-1-seropositive individuals, it was shown that all the HIV-1-positive samples in a panel from The Netherlands and 97% of the HIV-1-positive samples from Tanzania were identified by this IEIA. Six per cent of the IEIA-positive samples from Tanzania could not be confirmed in other assays. Testing of serial dilutions of serum samples from African individuals with confirmed HIV-1, HIV-2 or HIV(ANI70) infections in the K14 IEIA, indicated that a HIV-1-specific assay based on this principle may be developed.
| Additional Metadata | |
|---|---|
| , , , , , , , , , | |
| hdl.handle.net/1765/3425 | |
| AIDS | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Teeuwsen, V. J. P., Schalken, J., van der Groen, G., van den Akker, R., Goudsmit, J., & Osterhaus, A. (1991). An inhibition enzyme immunoassay, using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, for the serology of HIV-1 infections. AIDS, 5(7), 893–896. Retrieved from http://hdl.handle.net/1765/3425 |
|
